Cargando…

A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment

BACKGROUND: Studies 4658-201/202 (201/202) evaluated treatment effects of eteplirsen over 4 years in patients with Duchenne muscular dystrophy and confirmed exon-51 amenable genetic mutations. Chart review Study 4658-405 (405) further followed these patients while receiving eteplirsen during usual c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitelman, Olga, Abdel-Hamid, Hoda Z., Byrne, Barry J., Connolly, Anne M., Heydemann, Peter, Proud, Crystal, Shieh, Perry B., Wagner, Kathryn R., Dugar, Ashish, Santra, Sourav, Signorovitch, James, Goemans, Nathalie, McDonald, Craig M., Mercuri, Eugenio, Mendell, Jerry R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842766/ https://www.ncbi.nlm.nih.gov/pubmed/34420980 http://dx.doi.org/10.3233/JND-210665

Ejemplares similares

Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls
por: Mendell, Jerry R., et al.
Publicado: (2021)

Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
por: Mendell, Jerry R., et al.
Publicado: (2016)

Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial
por: McDonald, Craig M., et al.
Publicado: (2021)

Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophy
por: Alfano, Lindsay N., et al.
Publicado: (2019)

Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History
por: Kinane, T. Bernard, et al.
Publicado: (2018)

FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2017)

Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
por: Khan, Navid, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
por: Brogna, Claudia, et al.
Publicado: (2019)

Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
por: Brogna, Claudia, et al.
Publicado: (2019)

Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
por: Pane, Marika, et al.
Publicado: (2014)

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
por: Pane, Marika, et al.
Publicado: (2015)

Eteplirsen Use in a Boy with Duchenne Muscular Dystrophy and Sickle Cell Anemia
por: Aiello, Gregory M., et al.
Publicado: (2022)

Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USA
por: Iff, Joel, et al.
Publicado: (2023)

Estimating density of forest bats and their long‐term trends in a climate refuge
por: Law, Bradley, et al.
Publicado: (2023)

Follistatin Gene Therapy Improves Ambulation in Becker Muscular Dystrophy
por: Al-Zaidy, Samiah A., et al.
Publicado: (2015)

Early Neurological Assessment and Long-Term Neuromotor Outcomes in Late Preterm Infants: A Critical Review
por: Romeo, Domenico M., et al.
Publicado: (2020)

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
Publicado: (2015)

Comparison of Self-Reported vs Objective Measures of Long-Term Community Ambulation in Lower Limb Prosthesis Users
por: Godfrey, Bradeigh, et al.
Publicado: (2022)

Long-Term Safety and Efficacy Data of Golodirsen in Ambulatory Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A First-in-human, Multicenter, Two-Part, Open-Label, Phase 1/2 Trial
por: Servais, Laurent, et al.
Publicado: (2022)

Why Is Long-Term Therapy Required to Cure Tuberculosis?
por: Connolly, Lynn E, et al.
Publicado: (2007)

Suitability of external controls for drug evaluation in Duchenne muscular dystrophy
por: Goemans, Nathalie, et al.
Publicado: (2020)

The Darlington and Northallerton Long Term Asthma Study: pulmonary function
por: Connolly, C Kevin, et al.
Publicado: (2005)

Independent and Combined Effects of Telomere Shortening and mtDNA(4977) Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
por: Vecoli, Cecilia, et al.
Publicado: (2019)

Stochastic Induction of Long-Term Potentiation and Long-Term Depression
por: Antunes, G., et al.
Publicado: (2016)

Weather factors in the short-term forecasting of daily ambulance calls
por: Wong, Ho-Ting, et al.
Publicado: (2013)

Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics
por: Cripe, Timothy P., et al.
Publicado: (2022)

Suicidality and Suicide Attempt in a Young Female on Long-Term Sertraline Treatment
por: Santra, Ranjita, et al.
Publicado: (2012)

Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model
por: Siemionow, Maria, et al.
Publicado: (2022)

Long-term potentiation and long-term depression: a clinical perspective
por: Bliss, Timothy V.P., et al.
Publicado: (2011)

Sulfotransferase activity contributes to long-term potentiation and long-term memory
por: Sahoo, Biswaranjan, et al.
Publicado: (2022)

Long COVID: long-term effects?
por: Di Toro, Alessandro, et al.
Publicado: (2021)

Long‐term fire and vegetation change in northwestern Amazonia
por: Heijink, Britte M., et al.
Publicado: (2022)

Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy
por: Siemionow, Maria, et al.
Publicado: (2022)

Long-Term Collection
por: Staff Association
Publicado: (2016)

Long-Term Collections
por: Staff Association
Publicado: (2016)

Long-term future
por: Johnsen, Kjell
Publicado: (1989)

Long-Term Collections
por: Staff Association
Publicado: (2023)

Long term collections
por: Collectes à long terme
Publicado: (2013)

Long-term collections
por: Collectes à long terme
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_pfn9d8v367jqn128l1djk5gp9u